Hospice Finance Whistleblowers: When the Census Becomes a Liability

A hospice finance whistleblower can connect patient census, compensation and cap liabilities to false Medicare claims. You see which admissions drive a bonus, what an audit does to expected revenue and whether management accounts for repayment or keeps billing. In a hospice fraud case, that financial history can explain why patients stayed enrolled and who knew the payments were wrong.

The nurse sees the patient’s condition. Finance sees the admissions target, the payment and the warning that reached management. Among hospice whistleblowers, a former vice president of finance brought the case against Hospice of the Comforter. His complaint connects Medicare denials, financial projections and the information reaching the board.

How Hospice Payment Turns a Census Into Revenue

Medicare pays routine hospice care for each eligible enrolled day, including days without a visit. The hospice takes responsibility for the covered care related to the terminal illness, including drugs, equipment and nursing services. The daily census therefore drives revenue while the care delivered drives costs.

The four payment levels also matter to the amount on the claim. Routine home care, general inpatient care and inpatient respite use daily rates. Continuous home care pays by the hour for qualifying crisis care. A finance employee can see the billed level across patients and compare it with staffing, hours and clinical records. Upcoding routine home care to general inpatient or continuous home care can produce higher payments without the patient needing that level of care.

Eligibility turns on a physician’s prognosis of six months or less if the illness runs its normal course. Patients can continue receiving hospice through recertification when they remain eligible. Admission and recertification records connect the enrolled days to the medical basis for payment.

A 2015 study by the HHS Office of Inspector General, Medicare Hospices Have Financial Incentives to Provide Care in Assisted Living Facilities, examined Medicare claims from 2007 through 2012. It found longer stays and higher payments for beneficiaries in assisted living than in other settings, often with diagnoses requiring less complex care. Its explanation of the incentive is blunt:

The business has another incentive, too: its reputation for care. Quality, Reputation, and Reimbursement Design in the Hospice Industry, a 2026 Kansas State University working paper, models competition among California hospices. It finds that stronger reputation effects improve quality, measured through visits per patient day, while lower reimbursement reduces it. For finance, the useful question is what management chose to reward and fund: admissions, continued enrollment, visits or some combination of them.

Inappropriate enrollment also reaches beyond the books. Medicare hospice does not pay for curative treatment of the terminal illness, so an ineligible patient enrolled in hospice may unknowingly forgo needed treatment.

What Evidence Is Needed to Prove Fraud?

We work with you to connect the patient, the claim, the financial incentive and the decision behind it. An admissions report becomes more revealing beside the bonus schedule, the clinical objection and the claims that followed.

Admissions and retention reports show who entered, who stayed and when discharge was recommended. Bonus plans and scorecards show which results affected pay. Earlier chart versions, review minutes and messages can explain why an objection disappeared or a discharge was delayed.

Finance reports also explain what the business expected to earn. In its fiscal 2025 annual report, Enhabit published hospice admissions, patient days, average daily census, and revenue and cost per patient day.

Audit findings belong beside repayment analyses, escalation emails, board materials and claims submitted after notice. Together, these records show the business decision behind the bill.

When Bonuses Keep Patients on the Census

Compensation can connect an admissions target to a false claim when staff are rewarded for enrolling or retaining patients who do not qualify.

Hospice Care of Kansas and its parent Voyager agreed to a $6.1 million settlement in 2012. The government alleged that clinical employees received compensation based on census and admissions, patients’ discharges were delayed after they no longer had the required prognosis, and staff received instructions to document conditions misleadingly. The company allegedly paid for the head count while shaping the records that kept it payable.

At Good Shepherd Hospice, the government alleged enrollment-based bonuses for marketers, admissions nurses and executive directors. It also alleged that the company selected medical directors for their ability to refer patients, particularly through nursing homes. The same growth target could reach the person recruiting the patient and the person involved in the clinical decision.

That is where compensation and referral payments meet. We examine what the agreement paid for, what work was performed and which patients came through the relationship. A monthly payment, a referral list and a time record answer different parts of that question.

What the Cap Records Show

The Medicare aggregate cap limits a provider number’s annual hospice payments. Its calculation compares payments with a cap amount multiplied by qualifying beneficiary shares. The accounting therefore follows the billing number and the patients assigned to it.

Chemed’s fiscal 2025 annual report described 59 VITAS programs operating under 33 Medicare provider numbers. A corporate census total can conceal the different cap positions of the programs within it. The relevant finance records connect each program, its billing number, the payments received and the beneficiary count used for that number.

A patient’s share of the cap calculation can be split across hospices and years. Admissions, transfers, discharges and reelections therefore belong beside the worksheet. Additional qualifying beneficiary shares raise the ceiling.

The Medicare Payment Advisory Commission estimated that 28% of hospices exceeded the aggregate cap in 2023 in its March 2026 report to Congress. The cap creates a payment obligation that finance must account for and management must address.

The effect is visible in company accounting. Chemed reported a $27.2 million Medicare cap revenue reduction in 2025, reflecting projected liabilities for the 2025 and 2026 measurement periods. That disclosure shows how cap exposure reaches reported revenue before the final payment position is settled.

For a finance insider, the comparison runs from the cap estimate to the recorded liability, the contractor’s notice, the repayment analysis and management’s response. A change in the estimate has inputs behind it. A sudden change in admissions or discharge patterns has decisions behind it. We examine how those decisions affected both patient care and the money the hospice expected to keep.

When Management Knows and Keeps Billing

Internal audits, clinical warnings and repayment analyses can show that management knew about improper claims and continued billing or kept earlier payments. Finance and compliance staff may know when that information arrived and what happened to it.

Hospice of the Comforter agreed to a $3 million settlement in 2013. The government alleged admissions regardless of eligibility, falsified records, limits on physicians’ assessments and delayed discharges. The former finance vice president’s complaint describes the financial response inside the hospice.

The government also alleged that an internal review after audit notice led to the discharge of at least 150 ineligible patients. The finance question is what that census drop meant for projected revenue and payments already received.

He alleged that a follow-on Medicare review produced a 77% denial rate and that the hospice took no action to refund earlier payments for those patients. He also described presenting the board with a falling census, Medicare denials and financial projections, followed by an instruction from the chief executive to make future presentations positive.

The alleged treatment of an outside compliance review is even more direct:

In that allegation, even the consultant’s fee was shaped around keeping the findings off paper. The engagement terms and the information presented to the board belong in the same financial story as the denied claims.

Caris Healthcare provides a parallel. Its $8.5 million settlement in 2018 addressed allegations that it billed for ineligible patients and retained overpayments. The government said internal audits, the chief medical officer and nurses had alerted the company, yet it continued billing and took no meaningful action to determine whether earlier payments were improper.

The review’s scope matters alongside its findings: which patients and periods it covered, what management learned, and whether its repayment analysis addressed the wider problem. A discharge recommendation, an audit finding and the next claim can show how the warning traveled through the business.

What If a Hospice Billing Employee Discovers Duplicate Claims?

If a hospice billing employee discovers duplicate claims, the useful comparison connects the same patient, service dates, provider numbers and payments. We examine the admission, transfer and certification records behind the apparent overlap.

In the whistleblower complaint against Health and Palliative Services of the Treasure Coast, the allegation was specific: patients were discharged from one facility and readmitted to another on the same day, then Medicare was billed for two days of care for that single day. The complaint connects the duplicate billing to manipulated census data.

Other complaints describe different mechanisms. Whistleblowers alleged that AseraCare billed again for a gap period after backdating a new certification period, and billed medication twice after relabeling a deceased patient’s medication for another patient. A complaint against Hernando-Pasco Hospice alleged overlapping hospice and skilled-nursing billing for care that should have been paid under one benefit. These allegations point to different comparisons: the certification history, the medication and patient records, or the overlapping benefit claims.

For a billing employee, the important detail is how the second payment was produced. The census entry, the certification date and the benefit billed can explain a duplicate that a revenue total leaves hidden.

How Much Does a Whistleblower Payout on Medicare Fraud?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. Your knowledge of health care finances can connect the payments to the decisions behind them. We work with you to assess that connection and build a healthcare whistleblower case around the evidence.

You Know What the Numbers Mean

If you work in hospice finance, billing or compliance and know why the census, payments and internal warnings do not agree, speak with our whistleblower experts about what you see. We build the financial account of the scheme with you, bring in hospice fraud whistleblower lawyers who understand Medicare payment disputes, and stay beside you through the case to build your strongest hospice whistleblower case.